E-LIB Suche - Ergebnisse für: Kishimoto, Junji

1

Changing trends in traumatic spinal cord injury in an aging..:

Yokota, Kazuya ; Sakai, Hiroaki ; Kawano, Osamu...
PLOS ONE. 19 (2024) 5 - p. e0298836 , 2024

Link: https://doi.org/10.1371/..

2

Association of baseline electrocardiographic left ventricul..:

Ikeda, Shota ; Shinohara, Keisuke ; Tagawa, Koshiro...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

GnRH antagonist monotherapy versus a GnRH agonist plus bica..:

Yokomizo, Akira ; Shiota, Masaki ; Morokuma, Futoshi...
International Journal of Urology. 31 (2023) 4 - p. 362-369 , 2023

Link: https://doi.org/10.1111/..

4

Development of deep-learning models for real-time anaerobic..:

Watanabe, Tatsuya ; Tohyama, Takeshi ; Ikeda, Masataka...
European Journal of Preventive Cardiology. 31 (2023) 4 - p. 448-457 , 2023

Link: https://doi.org/10.1093/..

5

Association of Serum Oxysterols with Cholesterol Metabolism..:

Akiyama, Yusuke ; Katsuki, Shunsuke ; Matoba, Tetsuya...
Nutrients. 15 (2023) 13 - p. 2997 , 2023

Link: https://doi.org/10.3390/..

6

Association between Serum Oxysterols and Coronary Plaque Re..:

Nakano, Yasuhiro ; Yamamoto, Mitsutaka ; Matoba, Tetsuya...
Journal of Atherosclerosis and Thrombosis. 30 (2023) 8 - p. 907-918 , 2023

Link: https://doi.org/10.5551/..

7

A higher resting heart rate is associated with cardiovascul..:

Ikeda, Shota ; Shinohara, Keisuke ; Enzan, Nobuyuki...
Hypertension Research. 46 (2023) 5 - p. 1090-1099 , 2023

Link: https://doi.org/10.1038/..

8

CD14 down‐modulation as a real‐time biomarker in Kawasaki d..:

Inada, Yutaro ; Sonoda, Motoshi ; Mizuno, Yumi...
Clinical & Translational Immunology. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

9

3-day intervention program for family members of hikikomori..:

Kubo, Hiroaki ; Urata, Hiromi ; Sakai, Motohiro...
Frontiers in Psychiatry. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

Evaluating the efficacy and safety of acotiamide in patient..:

Esaki, Mitsuru ; Ihara, Eikichi ; Manabe, Noriaki...
Trials. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

Efficacy and safety of edoxaban in patients with chronic th..:

Hosokawa, Kazuya ; Abe, Kohtaro ; Kishimoto, Junji...
BMJ Open. 12 (2022) 7 - p. e061225 , 2022

Link: https://doi.org/10.1136/..

12

Safety, tolerability, and anti-fibrotic efficacy of the CBP..:

Kimura, Kiminori ; Kanto, Tatsuya ; Shimoda, Shinji...
eBioMedicine. 80 (2022) - p. 104069 , 2022

Link: https://doi.org/10.1016/..

13

A Phase II Trial on Osimertinib as a First-Line Treatment f..:

Chihara, Yusuke ; Takeda, Takayuki ; Goto, Yasuhiro...
The Oncologist. 27 (2022) 11 - p. 903-e834 , 2022

Link: https://doi.org/10.1093/..

14

Effects of Medications and Subthalamic Nucleus-Deep Brain S..:

Urasaki, Eiichirou ; Miyagi, Yasushi ; Kishimoto, Junji
Neuromodulation: Technology at the Neural Interface. , 2022

Link: https://doi.org/10.1111/..

15

ASXL1 mutations with serum EPO levels predict poor response..:

Morita, Yasuyoshi ; Nannya, Yasuhito ; Ichikawa, Motoshi...
International Journal of Hematology. 116 (2022) 5 - p. 659-668 , 2022

Link: https://doi.org/10.1007/..